跳至主要内容
临床试验/NCT00700596
NCT00700596已完成早期 1 期

Psychotomimetic Effects of Kappa Opioid Receptor Agonist Salvinorin A in Healthy Controls

Yale University1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2009年2月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
105
试验地点
1
主要终点
Positive and Negative Syndrome Scale, Clinician Administered Dissociative Symptoms Scale, Visual Analog Scale, Assessment of Opioid Effects, Cognitive Testing

研究概览

简要总结

This study evaluates the effects of Salvinorin A (SA). SA is the active ingredient of the plant Salvia divinorum that is known to have been used by Mexican Indians as part of religious rituals. The purpose of this project is to understand what people experience when they consume Salvinorin A.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Previous exposure to inhaled Salvinorin A (SA).

排除标准

  • 未提供

研究组 & 干预措施

1

Active Comparator

Salvinorin A (SA)

干预措施: Salvinorin A (Drug)

2

Placebo Comparator

Control or Placebo SA

干预措施: Placebo (Drug)

结局指标

主要结局

Positive and Negative Syndrome Scale, Clinician Administered Dissociative Symptoms Scale, Visual Analog Scale, Assessment of Opioid Effects, Cognitive Testing

时间窗: Time Frame: -30, +10, +30, +90, +120. +200

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohini Ranganathan

Associate Professor of Psychiarty

Yale University

研究点 (1)

Loading locations...

相似试验